OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS
PYRANTEL PAMOATE 144 MG (equivalent to 50 mg pyrantel base)
ACTIVE INGREDIENTS
PYRANTEL PAMOATE 144 MG (equivalent to 50 mg pyrantel base)
PURPOSE
Pinworm treatment
USES
FOR THE TREATMENT OF PINWORMS.
WARNINGS
Do not Exceed recommended usage
Whenm using this product abdominal cramps, nausea, vomiting, diarrhea, headache, or dizziness sometimes occur after taking this drug. If any of these conditions persist consult a doctor.
Ask a doctor before use if you have liver disease
If pregnant or breast-feeding, ask a health professional before use.
KEEP OUT OF REACH OF CHILDREN. In case of accidental overdose, seek medical attention or contact a Poison Control Center Immediately.
Directions
Read package insert carefully before taking this medication. Take only according to directions and do not exceed the recommended dosage unless direct by a doctor. Medication should only be taken one time as a single dose; do not repeat treatment unless direct by a doctor. When one individual in a household has pinworms, the entire household should be treated unless otherwise advised. See Warnings. If any worms other than pinworms are present before or after treatmen, consult a doctor. If any symptoms or pinworms are still present after treatment, consult a doctor.
| Weight | Single Dose |
| Less than 25 pounds or under 2 years of age | Do not use unless directed by a doctor |
| 25 to 37 pounds | 1/2 teaspoonful (2.5 mL) |
| 38 to 62 pounds | 1 teaspoonful (5 mL) |
| 63 to 87 pounds | 1 1/2 teaspoonfuls (7.5 mL) |
| 88 to 112 pounds | 2 teaspoonfuls (10 mL) |
| 113 to 137 pounds | 2 1/2 teaspoonfuls (12.5 mL) |
| 138 to 162 pounds | 3 teaspoonfuls (15 mL) |
| 163 to 187 pounds | 3 1/2 teaspoonfuls (17.5 mL) |
| 188 pounds and over | 4 teaspoonfuls (20 mL) |
Shake well before use. This product can be taken any time of day, with or without meals. It may be taken alone or with milk or fruit juice. Use of a laxative is not necessary prior to, during, or after medication.
INACTIVE INGREDIENTS
acesulfame potassium, cherry flavor, citric acid, glycerin, methylparaben, polysorbate 80, potassium sorbate, propylene glycol, propylparaben, sodium bezoate, sodium carboximethylcellulose, sodium citrate, sorbitol, water, xanthan gum
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 199106 | pyrantel pamoate 144 MG in 1 mL Oral Suspension | PSN | 4 |
| 199106 | pyrantel pamoate 144 MG/ML Oral Suspension | SCD | 4 |
| 199106 | pyrantel pamoate 144 MG per 1 ML Oral Suspension | SY | 4 |
| 199106 | pyrantel pamoate 144 MG/ML (pyrantel base 50 MG/ML) Oral Suspension | SY | 4 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53145-101-11 | 2023-07-28 | C162847 | 48780-1 | 9d75b9d0-8866-f424-e053-dadaa90a57ce | PARASITOL |
| 53145-101-11 | 2021-08-09 | C162847 | 48780-1 | 9d75b9d0-8866-f424-e053-dadaa90a57ce | PARASITOL |
| 53145-101-11 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8866-f424-e053-dadaa90a57ce | PARASITOL |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53145-101-01 | PARASITOL | 30 mL in 1 BOTTLE | SUSPENSION | 30 | 4 | |
| 53145-101-11 | PARASITOL | 1 in 1 BOX | SUSPENSION | 1 | 4 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PYRANTEL PAMOATE | ACTIVE INGREDIENT | 81BK194Z5M | 1 | |
| PYRANTEL | ACTIVE MOIETY | 4QIH0N49E7 | 1 | |
| CARBOXYMETHYLCELLULOSE | INACTIVE INGREDIENT | 05JZI7B19X | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 53145-101 | 53145-101-01, 53145-101-11 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACESULFAME POTASSIUM | 23OV73Q5G9 | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SORBITOL | 506T60A25R | IACT |
| WATER | 059QF0KO0R | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| PYRANTEL PAMOATE | 81BK194Z5M | ACTIM |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| CARBOXYMETHYLCELLULOSE | CARBOXYMETHYLCELLULOSE | 05JZI7B19X | SUSPENSION / ORAL | 50.07 mg/5ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| CARBOXYMETHYLCELLULOSE | CARBOXYMETHYLCELLULOSE | 05JZI7B19X | SUSPENSION / ORAL | 50.07 mg/5ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| CARBOXYMETHYLCELLULOSE | CARBOXYMETHYLCELLULOSE | 05JZI7B19X | SUSPENSION / ORAL | 50.07 mg/5ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PARASITOL | PYRANTEL PAMOATE | Menper Distributors Inc. | cd5eb4c9-d0f0-4be7-84eb-88ebc4632dc6 | 2025-07-22 | Warnings | 53145-101-01 53145-101-11 53145-101 53145010111 53145010101 3a8a63ea-ec4f-58e7-e063-6394a90a3110 cd5eb4c9-d0f0-4be7-84eb-88ebc4632dc6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.